To this end, we investigated the densities of tumor-infiltrating CD3+, CD8+ and CD45RO+ T cells in a large sample of NB patients using digital pathology and developed a new immunoscore, summarizing such densities, to assess its role in predicting OS and event-free survival (EFS) of NB patients. The gene discussed is CD8A; the disease is neuroblastoma.